Enoxaparin sodium is a new antithrombotic drug, which is used to prevent the formation of deep static thrombosis and pulmonary embolism, treat existing deep venous thrombosis, and treat unstable angina pectoris. It is the first choice of anticoagulation and antithrombotic drugs.

　　Enoxaparin sodium belongs to low molecular weight heparin, which is obtained by alkaline depolymerization of heparin sodium salt extracted from pig intestinal mucosa after benzyl esterification. The main mechanism of action is that this product enhances the inhibitory effect of factor Xa and thrombin (na factor) by binding with antithrombin m and its complex.

　　Compared with ordinary heparin, enoxaparin sodium has the advantages of strong antithrombotic effect, small bleeding risk, high bioavailability, long half-life and easy use, and enoxaparin sodium injection is one of the best selling antithrombotic drugs in the world.